Marianne Uteng

Marianne Uteng is a Principal at the Novartis Venture Fund (NVF) in Basel, Switzerland. Prior to joining NVF, she worked at Novartis Global Drug Development and, before that, in the Pre-Clinical Safety Department at the Novartis Institutes of Biomedical Research, where she led teams delivering health authority-required and non-routine safety assessments for early and late-stage programs across many therapeutic areas. Concurrently, she supported the Novartis BD&L Search & Evaluation Team and spearheaded collaborations with biotechnology companies and academia for development of innovative in vitro/in vivo systems. Marianne received her MSc in Biochemistry from the University of Oslo and her PhD in Molecular Biology, Cell Biology and Biophysics from a joint program between European Molecular Biology Laboratories and the University of Oslo.